Acceleron Pharma Reaches Analyst Target Price
January 29, 2020 at 08:25 AM EST
In recent trading, shares of Acceleron Pharma, Inc. (XLRN) have crossed above the average analyst 12-month target price of $63.22, changing hands for $79.39/share..
